Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis
Objectives Previous observational studies evaluating the relationship of VEGFA rs2010963
polymorphism with cancer risk reported inconsistent outcomes. We conducted this meta …
polymorphism with cancer risk reported inconsistent outcomes. We conducted this meta …
Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis
CH Chen, CH Ho, SKH Huang, CH Shen, CC Wu… - Cytokine, 2020 - Elsevier
Background Vascular endothelial growth factor (VEGF) is the key regulator of angiogenesis
in the development of various cancers. Previous studies have examined the relationship …
in the development of various cancers. Previous studies have examined the relationship …
The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer
M El Azzouzi, H El Ahanidi, C Hafidi Alaoui, I Chaoui… - Diagnostics, 2023 - mdpi.com
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR1 and VEGFR2) are the
most important tissue factors involved in tumor growth and angiogenesis. The aim of this …
most important tissue factors involved in tumor growth and angiogenesis. The aim of this …
eNOS and VEGF variants might increase the risk of pancreatic cancer
Background: Endothelial nitric oxide synthase (eNOS) is essential in chronic inflammation
and carcinogenesis. The association between variants in vascular endothelial growth factor …
and carcinogenesis. The association between variants in vascular endothelial growth factor …
Qualification and quantification of plasma cell-free DNA after long-term storage conditions in patients with benign prostatic hyperplasia (BPH): a pilot study
A Bozkurt, M Gürbüzel, I Sayar, S Baydeniz… - Journal of Laboratory …, 2022 - degruyter.com
Objectives Free DNA is used as a cancer biomarker due to its low cost, high applicability,
and fast, reliable results compared to invasive methods. This study aimed to evaluate the …
and fast, reliable results compared to invasive methods. This study aimed to evaluate the …
[PDF][PDF] The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer. Diagnostics 2023, 13 …
M El Azzouzi, H El Ahanidi, C Hafidi Alaoui, I Chaoui… - 2023 - academia.edu
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR1 and VEGFR2) are the
most important tissue factors involved in tumor growth and angiogenesis. The aim of this …
most important tissue factors involved in tumor growth and angiogenesis. The aim of this …
Molecular markers of VEGF, TNF-α and TNF-β IN bladder cancer patients at stage T3N0M0 and their relationship with the degree of tumor neoplasia
O Fedevych, V Fedevych, S Pasichnyk - Journal of Education, Health …, 2023 - apcz.umk.pl
Abstract 17 bladder cancer patients, stage T 3 N 0 M 0 (main group), were included in the
study. There were 10 men (mean age 58.2±6.2 years) and 7 women (mean age 59.5±2.4 …
study. There were 10 men (mean age 58.2±6.2 years) and 7 women (mean age 59.5±2.4 …